Vaccine innovations for emerging infectious diseases-a symposium report

Ann N Y Acad Sci. 2020 Feb;1462(1):14-26. doi: 10.1111/nyas.14235. Epub 2019 Oct 28.


Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled "Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats," held on May 20, 2019.

Keywords: CMV; DNA vaccine; Ebola; HIV; MERS; RNA vaccine; RSV; Zika; antimicrobial resistance; infectious disease; influenza; malaria; maternal immunization; monoclonal antibodies; systems vaccinology; tuberculosis; vaccine; vaccinology.

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic / methods
  • Communicable Disease Control
  • Communicable Diseases / drug therapy
  • Communicable Diseases / epidemiology
  • Communicable Diseases, Emerging / epidemiology
  • Communicable Diseases, Emerging / prevention & control*
  • Congresses as Topic / trends*
  • Humans
  • New York City
  • Research Report / trends*
  • Therapies, Investigational / methods
  • Therapies, Investigational / trends*
  • Vaccines / administration & dosage*


  • Vaccines